Influenza vaccination during the 2021/22 season: A data-linkage test-negative case-control study of effectiveness against influenza requiring emergency care in England and serological analysis of primary care patients
We present England 2021/22 end-of-season adjusted vaccine effectiveness (aVE) against laboratory confirmed influenza related emergency care use in children aged 1-17 and in adults aged 50+, and serological findings in vaccinated vs unvaccinated adults by hemagglutination inhibition assay. Influenza vaccination has been routinely offered to all children aged 2-10 years and adults aged 65 years + in England. In 2021/22, the offer was extended to children to age 15 years, and adults aged 50-64 years. Influenza activity rose during the latter half of the 2021/22 season, while remaining comparatively low due to COVID-19 pandemi...
Source: Vaccine - February 11, 2024 Category: Allergy & Immunology Authors: Heather J Whitaker Katie Hassell Katja Hoschler Linda Power Julia Stowe Nicki L Boddington Camille Tsang Hongxin Zhao Ezra Linley Elizabeth Button Cecilia Okusi Carole Aspden Rachel Byford Simon deLusignan Gayatri Amirthalingam Maria Zambon Nick J Andrews Source Type: research
The lingering challenge: addressing vaccine hesitancy in a post-pandemic world
This article discusses the role of anti-vaxxers and vaccine-hesitant groups, electronic social media, and politics in vaccine hesitancy among people. It describes the strategies to combat the roadblocks in the vaccination programmes and health benefits, offered by recent advances in scientific and technological developments.PMID:38309708 | DOI:10.21101/cejph.a7593 (Source: Central European Journal of Public Health)
Source: Central European Journal of Public Health - February 3, 2024 Category: International Medicine & Public Health Authors: Ethan Ayaan Mir Source Type: research
